NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson Johnson

  • Written by ACN Newswire

image

SAN DIEGO, CA, Feb 19, 2020 - (ACN Newswire) - DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident of Johnson & Johnson Innovation - JLABS @ Shanghai, announced today that it has entered into a strategic collaboration with the Lung...

Read more: DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson Johnson